Literature DB >> 12189145

Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system.

Sandra Rösmann1, Dagmar Hahn, Daniel Lottaz, Markus-N Kruse, Walter Stöcker, Erwin E Sterchi.   

Abstract

The activation of latent proenzymes is an important mechanism for the regulation of localized proteolytic activity. Human meprin-alpha, an astacin-like zinc metalloprotease expressed in normal colon epithelial cells, is secreted as a zymogen into the intestinal lumen. Here, meprin is activated after propeptide cleavage by trypsin. In contrast, colorectal cancer cells secrete meprin-alpha in a non-polarized way, leading to accumulation and increased activity of meprin-alpha in the tumor stroma. We have analyzed the activation mechanism of promeprin-alpha in colorectal cancer using a co-culture model of the intestinal mucosa composed of colorectal adenocarcinoma cells (Caco-2) cultivated on filter supports and intestinal fibroblasts grown in the companion dish. We provide evidence that meprin-alpha is activated by plasmin and show that the presence of plasminogen in the basolateral compartment of the co-cultures is sufficient for promeprin-alpha activation. Analysis of the plasminogen-activating system in the co-cultures revealed that plasminogen activators produced and secreted by fibroblasts converted plasminogen to active plasmin, which in turn generated active meprin-alpha. This activation mechanism offers an explanation for the observed meprin-alpha activity in the tumor stroma, a prerequisite for a potential role of this protease in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189145     DOI: 10.1074/jbc.M206203200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

Review 2.  Meprin A metalloproteinase and its role in acute kidney injury.

Authors:  Gur P Kaushal; Randy S Haun; Christian Herzog; Sudhir V Shah
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20

3.  Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.

Authors:  Gail L Matters; Andrea Manni; Judith S Bond
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.

Authors:  Viola A Heinzelmann-Schwarz; Richard A Scolyer; James P Scurry; Alison N Smith; Margaret Gardiner-Garden; Andrew V Biankin; Sally Baron-Hay; Carolyn Scott; Robyn L Ward; Daniel Fink; Neville F Hacker; Robert L Sutherland; Philippa M O'Brien
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

5.  Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes.

Authors:  Satoshi Tsuzuki; Nobuhito Murai; Yuka Miyake; Kuniyo Inouye; Hirofumi Hirayasu; Toshihiko Iwanaga; Tohru Fushiki
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

6.  Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

Authors:  Markus-N Kruse; Christoph Becker; Daniel Lottaz; Danny Köhler; Irene Yiallouros; Hans-Willi Krell; Erwin E Sterchi; Walter Stöcker
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 7.  Meprins, membrane-bound and secreted astacin metalloproteinases.

Authors:  Erwin E Sterchi; Walter Stöcker; Judith S Bond
Journal:  Mol Aspects Med       Date:  2008-08-22

8.  Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.

Authors:  James P Villa; Greg P Bertenshaw; Judith S Bond
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

9.  PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Authors:  Laetitia Devy; Shafaat A Rabbani; Mark Stochl; Mary Ruskowski; Ian Mackie; Laurent Naa; Mark Toews; Reinoud van Gool; Jie Chen; Art Ley; Robert C Ladner; Daniel T Dransfield; Paula Henderikx
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Let it flow: Morpholino knockdown in zebrafish embryos reveals a pro-angiogenic effect of the metalloprotease meprin alpha2.

Authors:  André Schütte; Jana Hedrich; Walter Stöcker; Christoph Becker-Pauly
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.